Home › Stocks › RNAZ › Changes

Who bought & sold RNAZ (Q2 2026)

Funds holding (Q2 2026)8
New positions2
Added1
Reduced1
Exited1

As of Q2 2026, 8 institutional funds reported holding RNAZ (TransCode Therapeutics, Inc.): 2 opened new positions, 1 added, 1 trimmed and 1 exited entirely. 13F filings are quarter-end snapshots of positioning, not intra-quarter trades.

New positions (2)

Fund Shares Value Weight
Yorkville Advisors Global, LP New 19.64K $121.96K 0.1
Fidelity Management & Research (FMR) New 706 $4.38K —

Added to positions (1)

Fund Shares Value Weight Change
Tower Research Capital LLC (TRC) 677 $4.20K — +449 sh (+196.9%)

Reduced positions (1)

Fund Shares Value Weight Change
UBS Group AG 2.89K $17.93K — -5.41K sh (-65.2%)

Exited positions (1)

Held in the prior quarter but not reported in the latest filing.

Fund Shares Value Weight
Geode Capital Management Exited 12.74K $109.69K —